Pemigatinib
Drug timelines are a Plus or Pro feature.
16 regulatory and trial events tracked for Pemigatinib, covering 2022-01-21 to 2026-08-11. Get the full timeline:
Most recent: Clinical Trial Results: A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma [Phase 3]